Christopher R. Gordon - 14 Jun 2022 Form 4 Insider Report for Cerevel Therapeutics Holdings, Inc. (CERE)

Role
Director, 10%+ Owner
Signature
/s/ Christopher R Gordon
Issuer symbol
CERE
Transactions as of
14 Jun 2022
Transactions value $
$0
Form type
4
Filing time
16 Jun 2022, 17:11:01 UTC
Previous filing
14 Jun 2021
Next filing
09 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CERE Stock Option (Right to Buy) Award $0 +23.5K $0.00 23.5K 14 Jun 2022 Common Stock 23.5K $24.35 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the shares subject to this option shall vest and become exercisable on the earlier of: (i) the one year anniversary of the Grant Date, or (ii) the next annual meeting of stockholders of the Company occurring after the Grant Date.